Hi HK
The Hygea PO was announced on 30/1/19 and was to commence on 1/4/19 for the next 24 months with a total value of up to $22 million in US$. My apologies for saying $30 mill US.
Products were issued to Hygea and no revenues were ever received. It was then stated that Hygea were going to continue to use them for but for evaluation purposes only.
The Prizma should have been a win/win.
GMV get revenues, exposure and Hygea get to say they are at the front of cutting edge technology and patient care.
Neither happened.
The new ownership regime didn’t adopt the Prizma either. Why didn’t this product get adopted by the new regime after free evaluation time. It is supposed to be fantastic for Hospital management ( saving time, effort and $$$) and patient care.
- Forums
- ASX - By Stock
- GMV
- Ann: Trading Halt
Ann: Trading Halt, page-61
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)